Please login to the form below

Not currently logged in
Email:
Password:

Millennials’ disappointing medicine habits

Survey finds only 60% of 18-34 years olds take treatments as prescribed

Medicine

The UK has an ‘under-informed’ youth when it comes to prescription medicines, according to a new patient behaviour survey from the IPA’s Healthcare Group.

It found that 30% of younger patients - 18-34 year olds - are much more likely to find taking multiple medications a day confusing compared to their older (55+) counterparts (11%).

Additionally, the IPA’s investigation also exposed a dissatisfaction with younger patients and the amount of preliminary information they receive from HCPs compared with 90% of older patients.

Phil Bartlett, chair of the IPA Healthcare Group and MD at CDM, said: “It’s both an unsurprising and disappointing truth that in this research we see only 60% of people taking their medicine as prescribed.

“[There] is a huge opportunity for agencies and pharma clients to make life-changing differences by supporting patients and doctors with the right information at the right time to encourage people to take their medicines properly.”

All age ranges have also indicated that they would most like to find out about their medicine via an ‘easy to understand’ leaflet, and patients should “be able to find good support information, written in a way they can understand”, added Sarah Sowerby, member of the IPA Healthcare Group and founder of Wordbird.

She said: “Medicines need to be properly discussed with the people who will take them, whether they are old or young.”

Article by
Gemma Jones

13th December 2017

From: Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics